NASDAQ: CODXCo Diagnostics Inc Stock
$1.57+0.02 (+1.29%)
Updated May 4, 2026
CODX Price
$1.57
Fair Value Price
N/A
Market Cap
$5.66M
52 Week Low
$1.35
52 Week High
$46.50
P/E
-0.04x
P/B
0.27x
P/S
10.81x
PEG
N/A
Dividend Yield
N/A
Revenue
$622.49k
Earnings
-$46.90M
Gross Margin
64.3%
Operating Margin
-7,793.22%
Profit Margin
-7,533.6%
Debt to Equity
0.2
Operating Cash Flow
-$29M
Beta
1.43
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
CODX Overview
Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. The company was incorporated in 2013 and is based in Salt Lake City, Utah.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine CODX's potential to beat the market
- CODX doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Medical Device
Industry Rating
C
CODX
RankedUnranked of 94
RankedUnranked of 94
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $9.70 | A | |
| $10.68 | A | |
| $168.71 | A |
Be the first to know about important CODX news, forecast changes, insider trades & much more!
CODX News
Overview
Due Diligence Score
–
Industry Average (30)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how CODX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
CODX is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
CODX is good value based on its book value relative to its share price (0.27x), compared to the US Medical Devices industry average (2.99x)
P/B vs Industry Valuation
CODX is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more CODX due diligence checks available for Premium users.
Valuation
CODX fair value
Fair Value of CODX stock based on Discounted Cash Flow (DCF)
Price
$1.57
Fair Value
-$2.02
Undervalued by
177.79%
CODX is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
CODX price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-0.04x
Industry
22.35x
Market
16.69x
CODX price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.27x
Industry
2.99x
CODX is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
CODX's financial health
Profit margin
Revenue
$263.9k
Net Income
-$25.7M
Profit Margin
-9,755.1%
CODX's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
CODX's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$24.7M
Liabilities
$4.1M
Debt to equity
0.2
CODX's short-term assets ($13.69M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CODX's short-term assets ($13.69M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CODX's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
CODX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$6.2M
Investing
-$329.4k
Financing
$7.0M
CODX's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
CODX vs Medical Device Stocks
Co Diagnostics Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.